Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Trump Approved Nvidia's H200 Exports, but China's Limits Could Change Everything: https://g.foolcdn.com/editorial/images/846229/nvidia-data-center-with-nvidia-units-installed-showing-nvidia-logo.png
Trump Approved Nvidia's H200 Exports, but China's Limits Could Change Everything

After months of uncertainty, President Donald Trump announced that the U.S. government would permit Nvidia (NASDAQ: NVDA) to sell its H200 processors to China. Trump announced the decision in a post

Why Intel Is Massively Outperforming Nvidia and AMD This Year: https://g.foolcdn.com/editorial/images/846128/gemini_generated_image_qznfjfqznfjfqznf.jpeg
Why Intel Is Massively Outperforming Nvidia and AMD This Year

In today's video, I discuss recent updates affecting Intel (NASDAQ: INTC), Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: AMD), and other artificial intelligence (AI) stocks. To learn more,

AMD's CEO Makes an Interesting Prediction About Competitive AI Chips: https://g.foolcdn.com/editorial/images/846127/gemini_generated_image_d0gzcvd0gzcvd0gz.jpeg
AMD's CEO Makes an Interesting Prediction About Competitive AI Chips

In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD) and other artificial intelligence (AI) stocks. To learn more, check out the short video, consider

Nvidia Stock Pops After President Trump OKs Sales of New H200 AI Chips to China: https://g.foolcdn.com/editorial/images/846182/nvda-stock-ai-chips-export-to-china-h200-trump-ok-greenlights.png
Nvidia Stock Pops After President Trump OKs Sales of New H200 AI Chips to China

Nvidia (NASDAQ: NVDA) stock gained 2.3% in after-hours trading on Monday, following President Donald Trump's reportedly posting on Truth Social that the U.S. government will allow Nvidia to export

VALBIOTIS SA: Valbiotis announces completion of recruitment for the Cardio-Liver clinical study conducted with TOTUM•448 for metabolic liver diseases (MASLD)
VALBIOTIS SA: Valbiotis announces completion of recruitment for the Cardio-Liver clinical study conducted with TOTUM•448 for metabolic liver diseases (MASLD)
VALBIOTIS SA: Valbiotis announces completion of recruitment for the Cardio-Liver clinical study conducted with TOTUM•448 for metabolic liver diseases (MASLD)
EQS-News: Newron announces the US initiation of its ENIGMA-TRS 2 Phase III global clinical study with evenamide as an add-on therapy for patients with treatment-resistant schizophrenia (TRS)
EQS-News: Newron announces the US initiation of its ENIGMA-TRS 2 Phase III global clinical study with evenamide as an add-on therapy for patients with treatment-resistant schizophrenia (TRS)
EQS-News: Newron announces the US initiation of its ENIGMA-TRS 2 Phase III global clinical study with evenamide as an add-on therapy for patients with treatment-resistant schizophrenia (TRS)
This Artificial Intelligence (AI) Infrastructure Stock Could Be the Nvidia of 2026: https://g.foolcdn.com/editorial/images/845509/taiwan-semiconductor-tsmc-building-with-tsmc-logo-in-front_tsmc-4.jpg
This Artificial Intelligence (AI) Infrastructure Stock Could Be the Nvidia of 2026

For the last three years, one piece of hardware has continually earned credit for the rise of generative artificial intelligence (AI) applications: the semiconductor. Naturally, investors sought

Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge: https://cdn.content.foolcdn.com/images/1umn9qeh/production/34d887ed4212e8f7cd62f3cec35549f0cf9a39c0-1401x1251.png?w=1401&h=1251
Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge

New York City-based Newtyn Management reported a buy of nearly 1.6 million additional Indivior PLC shares, increasing its position by an estimated $62.8 million in the third quarter, according to a

3 Nuclear Energy Stocks to Buy Before 2026: https://g.foolcdn.com/editorial/images/845613/utilities-cooling-towers-getty-images.jpg
3 Nuclear Energy Stocks to Buy Before 2026

With energy demand surging globally, nuclear power is one energy source that checks all of the boxes. That's because it provides reliable, carbon-free power, providing consistent baseload energy

Prediction: This Artificial Intelligence (AI) Stock Will Be Worth More Than Palantir in 2026: https://g.foolcdn.com/editorial/images/845216/amd.jpg
Prediction: This Artificial Intelligence (AI) Stock Will Be Worth More Than Palantir in 2026

When OpenAI released ChatGPT to the masses at the end of November 2022, Palantir Technologies (NASDAQ: PLTR) had a $12.5 billion market capitalization. Today, the data-mining darling is worth more

Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now?: https://g.foolcdn.com/editorial/images/845277/doctor-talking-to-a-patient-while-making-notes.jpg
Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now?

Did you know that Summit Therapeutics (NASDAQ: SMMT) is one of the few publicly traded companies that has a market cap of more than $10 billion, but no revenue? With that kind of a valuation and

What AMD, CoreWeave, and Nebius Stock Investors Should Know About Recent Investor Conferences: https://g.foolcdn.com/editorial/images/845750/charts-85.png
What AMD, CoreWeave, and Nebius Stock Investors Should Know About Recent Investor Conferences

In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD), CoreWeave (NASDAQ: CRWV), and other AI stocks. To learn more, check out the short video, consider

Is This Growth Stock Still a Buy After a 20% Pullback?: https://g.foolcdn.com/editorial/images/845238/amd-headquarters-santa-clara-with-amd-logo-on-building_amd_advance.jpg
Is This Growth Stock Still a Buy After a 20% Pullback?

In this video, I will talk about the recent updates regarding Advanced Micro Devices (NASDAQ: AMD) and why I remain bullish on the name. Watch the short video to learn more, consider subscribing

Don't Buy Summit Therapeutics Until This Big Thing Happen: https://g.foolcdn.com/editorial/images/844994/fda-blocks-in-hand.jpg
Don't Buy Summit Therapeutics Until This Big Thing Happen

Sometimes, everything can seem to be going your way. And then the wheels fall off. That's the situation Summit Therapeutics (NASDAQ: SMMT) finds itself in.

Shares of the clinical-stage biotech

Billionaire David Tepper Dumped Intel and Oracle in the Past Quarter, and Piled Into These AI Infrastructure Stocks: https://g.foolcdn.com/editorial/images/844771/businesswoman_talking_with_a_colleague_in_a_meeting.jpg
Billionaire David Tepper Dumped Intel and Oracle in the Past Quarter, and Piled Into These AI Infrastructure Stocks

Appaloosa Management's founder, David Tepper, has long been known for his impressive and consistent returns on Wall Street. The billionaire investor and prominent hedge fund manager has built a name

2 Monster Stocks in the Making to Buy and Hold: https://g.foolcdn.com/editorial/images/844758/person-signing-into-their-online-banking-account.jpg
2 Monster Stocks in the Making to Buy and Hold

It's not possible to go back in time and invest in Nvidia or Amazon when they were still relatively small companies. However, it is possible to identify corporations that appear poised to establish

Could the Next Trillion-Dollar AI Opportunity Be in Cybersecurity and Not Semiconductors?: https://g.foolcdn.com/editorial/images/840299/gettyimages-1485822404-1201x713-d1f7813.jpg
Could the Next Trillion-Dollar AI Opportunity Be in Cybersecurity and Not Semiconductors?

Semiconductor stocks like Nvidia, Broadcom, and Advanced Micro Devices have produced tremendous long-term returns due to their artificial intelligence (AI) chips.

While semiconductors are the early

This AI Stock Hasn't Caught Up to Its Fundamentals Yet. Is the Market Sleeping on It?: https://g.foolcdn.com/editorial/images/843443/professional_seeming_surprised_after_reading_a_newspaper.jpg
This AI Stock Hasn't Caught Up to Its Fundamentals Yet. Is the Market Sleeping on It?

Most investors considering artificial intelligence (AI) stocks gravitate toward big names such as Nvidia, Broadcom, Advanced Micro Devices, and hyperscalers building large AI clusters. However

Can AMD Be a Trillion-Dollar Company?: https://g.foolcdn.com/editorial/images/844356/new-cc-2025-11-23t143117860.png
Can AMD Be a Trillion-Dollar Company?

In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the special offer link below.

Why Micron and SK Hynix Could Quietly Become the Real AI Winners: https://g.foolcdn.com/editorial/images/842500/businesswoman_analyzing_market_data_charts_on_desktop.jpg
Why Micron and SK Hynix Could Quietly Become the Real AI Winners

Investors who are looking for high-potential artificial intelligence (AI) stocks often pick well-known semiconductor players such as Nvidia and Advanced Micro Devices, hyperscalers such as Amazon

Every Investor Needs These 3 Takeaways From the Cardano (ADA) Summit 2025: https://g.foolcdn.com/editorial/images/842824/gettyimages-2168922157.jpg
Every Investor Needs These 3 Takeaways From the Cardano (ADA) Summit 2025

The wave of crypto optimism we've seen this year hasn't done much for Cardano (CRYPTO: ADA). The smart contract crypto's price is down 50% year over year and, at $0.41, is worth about 86% less than

2 Stocks That Have Turned $10,000 Into More Than $1 Million in 10 Years: https://g.foolcdn.com/editorial/images/842797/an-excited-investor.jpg
2 Stocks That Have Turned $10,000 Into More Than $1 Million in 10 Years

If you invest for the long term and are willing to be patient, you can generate life-changing returns. As long as you have the mindset that you're buying and holding for the future rather than

Institutional Titan Hits the Jackpot: Biotech Stock Surges by 116% on Buyout Offer: https://cdn.content.foolcdn.com/images/1umn9qeh/production/280eca1b4ecd8cc2401a2f4b2c3a68395e00dc85-1401x1251.png?w=1401&h=1251
Institutional Titan Hits the Jackpot: Biotech Stock Surges by 116% on Buyout Offer

On November 14, 2025, Bain Capital Life Sciences Investors, LLC disclosed a purchase of 520,310 shares of Cidara Therapeutics (NASDAQ:CDTX), increasing its position value by approximately $167.48

Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know.: https://g.foolcdn.com/editorial/images/842730/biotech-pharma-researchers-talk-lab.jpg
Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know.

Just prior to last week's takeover news, Cidara Therapeutics (NASDAQ: CDTX) was already one of the year's top-performing stocks. Trading in the mid-$20s at the start of 2025, by mid-November, this

Why Energizer Stock Plunged Today: https://g.foolcdn.com/editorial/images/843505/investor-gettyimages-1272168490.jpg
Why Energizer Stock Plunged Today

Shares of Energizer Holdings (NYSE: ENR) declined by more than 18% on Tuesday after the battery producer's profits fell short of investors' expectations.

Image source: Getty Images.

Energizer's net